Literature DB >> 27622301

Polyfunctional CD4 T-cells correlate with in vitro mycobacterial growth inhibition following Mycobacterium bovis BCG-vaccination of infants.

Steven G Smith1, Andrea Zelmer2, Rose Blitz3, Helen A Fletcher4, Hazel M Dockrell5.   

Abstract

BACKGROUND: Vaccination with Bacillus Calmette Guerin (BCG) protects infants against childhood tuberculosis however the immune mechanisms involved are not well understood. Further elucidation of the infant immune response to BCG will aid with the identification of immune correlates of protection against tuberculosis and with the design of new improved vaccines. The purpose of this study was to investigate BCG-induced CD4+ T-cell responses in blood samples from infants for cytokine secretion profiles thought to be important for protection against tuberculosis and compare these to PBMC-mediated in vitro mycobacterial growth inhibition.
METHODS: Blood from BCG-vaccinated or unvaccinated infants was stimulated overnight with Mycobacterium tuberculosis (M. tb) purified protein derivative (PPD) or controls and intracellular cytokine staining and flow cytometry used to measure CD4+T-cell responses. PBMC cryopreserved at the time of sample collection were thawed and incubated with live BCG for four days following which inhibition of BCG growth was determined.
RESULTS: PPD-specific IFNγ+TNFα+IL-2+CD4+T-cells represented the dominant T-cell response at 4monthsand1yearafter infant BCG. These responses were undetectable in age-matched unvaccinated infants. IL-17+CD4+T-cells were significantly more frequent in vaccinated infants at 4monthsbut not at 1-year post-BCG. PBMC-mediated inhibition of mycobacterial growth was significantly enhanced at 4monthspost-BCG as compared to unvaccinated controls. In an analysis of all samples with both datasets available, mycobacterial growth inhibition correlated significantly with the frequency of polyfunctional (IFNγ+TNFα+IL-2+) CD4+T-cells.
CONCLUSIONS: These data suggest that BCG vaccination of infants induces specific polyfunctional T-helper-1 and T-helper-17 responses and the ability, in the PBMC compartment, to inhibit the growth of mycobacteria in vitro. We also demonstrate that polyfunctional T-helper-1 cells may play a role in growth inhibition as evidenced by a significant correlation between the two.
Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  BCG; Cytokines; Infants; Mycobacterial growth inhibition; Polyfunctional; T-cells

Mesh:

Substances:

Year:  2016        PMID: 27622301     DOI: 10.1016/j.vaccine.2016.09.002

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  28 in total

1.  Listeria-Vectored Vaccine Expressing the Mycobacterium tuberculosis 30-Kilodalton Major Secretory Protein via the Constitutively Active prfA* Regulon Boosts Mycobacterium bovis BCG Efficacy against Tuberculosis.

Authors:  Qingmei Jia; Barbara Jane Dillon; Saša Masleša-Galić; Marcus A Horwitz
Journal:  Infect Immun       Date:  2017-08-18       Impact factor: 3.441

Review 2.  Vaccine Potential of Mycobacterial Antigens against Asthma.

Authors:  Abu Salim Mustafa
Journal:  Med Princ Pract       Date:  2020-05-18       Impact factor: 1.927

3.  BCG revaccination boosts adaptive polyfunctional Th1/Th17 and innate effectors in IGRA+ and IGRA- Indian adults.

Authors:  Srabanti Rakshit; Asma Ahmed; Vasista Adiga; Bharath K Sundararaj; Pravat Nalini Sahoo; John Kenneth; George D'Souza; Wesley Bonam; Christina Johnson; Kees Lmc Franken; Tom Hm Ottenhoff; Greg Finak; Raphael Gottardo; Kenneth D Stuart; Stephen C De Rosa; M Juliana McElrath; Annapurna Vyakarnam
Journal:  JCI Insight       Date:  2019-12-19

4.  In vitro analysis of antigen induced T cell-monocyte conjugates by imaging flow cytometry.

Authors:  Meseret Habtamu; Markos Abebe; Abraham Aseffa; Anne Margarita Dyrhol-Riise; Anne Spurkland; Greger Abrahamsen
Journal:  J Immunol Methods       Date:  2018-07-04       Impact factor: 2.303

5.  Mycobacterial Hsp65 antigen upregulates the cellular immune response of healthy individuals compared with tuberculosis patients.

Authors:  Pryscilla Fanini Wowk; Luís Henrique Franco; Denise Morais da Fonseca; Marina Oliveira Paula; Élcio Dos Santos Oliveira Vianna; Ana Paula Wendling; Valéria Maria Augusto; Silvana Maria Elói-Santos; Andréa Teixeira-Carvalho; Flávia Dias Coelho Silva; Solange Alves Vinhas; Olindo Assis Martins-Filho; Moisés Palaci; Célio Lopes Silva; Vânia Luiza Deperon Bonato
Journal:  Hum Vaccin Immunother       Date:  2017-01-06       Impact factor: 3.452

6.  Transcriptomic Analysis of CD4+ T Cells Reveals Novel Immune Signatures of Latent Tuberculosis.

Authors:  Julie G Burel; Cecilia S Lindestam Arlehamn; Nabeela Khan; Grégory Seumois; Jason A Greenbaum; Randy Taplitz; Robert H Gilman; Mayuko Saito; Pandurangan Vijayanand; Alessandro Sette; Bjoern Peters
Journal:  J Immunol       Date:  2018-03-30       Impact factor: 5.422

7.  Mycobacterial growth inhibition is associated with trained innate immunity.

Authors:  Simone A Joosten; Krista E van Meijgaarden; Sandra M Arend; Corine Prins; Fredrik Oftung; Gro Ellen Korsvold; Sandra V Kik; Rob Jw Arts; Reinout van Crevel; Mihai G Netea; Tom Hm Ottenhoff
Journal:  J Clin Invest       Date:  2018-04-03       Impact factor: 14.808

8.  Working together toward vaccines and biomarkers in the real world.

Authors:  Hazel M Dockrell
Journal:  Hum Vaccin Immunother       Date:  2017-06-02       Impact factor: 3.452

9.  Optimisation of a murine splenocyte mycobacterial growth inhibition assay using virulent Mycobacterium tuberculosis.

Authors:  Christina Jensen; Line Lindebo Holm; Erik Svensson; Claus Aagaard; Morten Ruhwald
Journal:  Sci Rep       Date:  2017-06-06       Impact factor: 4.379

10.  High-dose Mycobacterium tuberculosis aerosol challenge cannot overcome BCG-induced protection in Chinese origin cynomolgus macaques; implications of natural resistance for vaccine evaluation.

Authors:  Laura Sibley; Andrew D White; Karen E Gooch; Lisa M Stevens; Rachel Tanner; Ashley Jacobs; Owen Daykin-Pont; Fergus Gleeson; Anthony McIntyre; Randall Basaraba; Simon Clark; Graham Hall; Geoff Pearson; Emma Rayner; Helen McShane; Ann Williams; Mike Dennis; Philip D Marsh; Sally Sharpe
Journal:  Sci Rep       Date:  2021-06-10       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.